Prolidase Deficiency Causing Recalcitrant Leg Ulcerations in Siblings

Nancy Hajjar1, Mariam Kabbani, Rim Tannous

  • 1At the Division of Dermatology, Faculty of Medicine, Lebanese University, Beirut, Lebanon, Nancy Hajjar, MD, is Dermatology Resident; Mariam Kabbani, MD, is Dermatology Resident; and Rim Tannous, MD, is Dermatology Resident. Anne-Sophie Lebre, PhD, PharmD, is Biologist, Department of Genetics, Centre Hospitalier et Universitaire de Reims, Hôpital Maison Blanche, Reims, France. Andre Megarbane, MD, PhD, is Chair, Department of Human Genetics, Gilbert and Rose-Mary Chagoury School of Medicine, Byblos, Lebanon. Afaf Minari, MD, is Infectious Diseases Specialist, Department of Internal Medicine Infectious Diseases Division, Rafic Hariri University Hospital, Beirut. Fouad El Sayed, MD, is Professor of Dermatology, Division of Dermatology, Faculty of Medicine, Lebanese University. The authors have disclosed no financial relationships related to this article. Submitted March 16, 2021; accepted in revised form May 11, 2021.

Insights

This study details prolidase deficiency (PD), a rare genetic skin disorder caused by peptidase-D gene mutations. Treatment with a proline and glycine ointment showed partial improvement in chronic leg ulcers.

Area of Science:

  • Genetics
  • Dermatology
  • Biochemistry

Background:

  • Prolidase deficiency (PD) is a rare autosomal recessive genodermatosis.
  • It stems from mutations in the peptidase-D gene, affecting collagen metabolism.
  • Clinical presentations are variable, often including skin issues and systemic findings.

Observation:

  • Two siblings presented with dysmorphic features, abnormal blood work, and chronic, treatment-resistant leg ulcers.
  • Genetic analysis identified a homozygous pathogenic variant (c.549-1G > A) in the peptidase-D gene.
  • The patients had long-standing, severe leg ulcerations.

Findings:

  • A compounded topical ointment containing 5% proline and 5% glycine was administered daily.
  • Partial healing of leg ulcerations was observed within three months of treatment initiation.
  • Treatment efficacy was evaluated over an 8-month follow-up period.

Implications:

  • This case report highlights a potential therapeutic approach for prolidase deficiency.
  • It suggests incorporating PD into the differential diagnosis for chronic leg ulcers, especially in young patients.
  • Further research into topical proline and glycine therapy for PD-related ulcerations is warranted.

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
86.1K
Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
2.5K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
334
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.3K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
71
Probability Laws01:49

Probability Laws

Overview
42.3K